NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Angiodynamics Inc (NQ: ANGO)
20.23 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 4:00 PM EDT, Apr 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 20.22 (10)
Ask (Size) 21.31 (5)
Prev. Close 20.23
Today's Range 20.23 - 20.23
52wk Range 18.11 - 25.48
Shares Outstanding 36,804,506
Dividend Yield N/A
Performance
YTD
+2.17%
+2.17%
1 Month
-8.63%
-8.63%
3 Month
-3.48%
-3.48%
6 Month
-1.75%
-1.75%
1 Year
-1.08%
-1.08%
Top News
More News
Report: Developing Opportunities within 22nd Century Group, Darling Ingredients, Silvercorp Metals, Trevena, Star Bulk Carriers, and AngioDynamics — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of 22nd Century Group, Inc... Read More
from GlobeNewswire News Releases
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, today announced that it has... Read More
from Business Wire News Releases
More News
Read More
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer
from Business Wire News Releases
RSI Alert: AngioDynamics (ANGO) Now Oversold
category Stocks
from Market News Video
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
from Business Wire News Releases
AngioDynamics to Present at the Needham Healthcare Conference
from Business Wire News Releases
Notable Tuesday Option Activity: STMP, ANGO, FAST
category Stocks
from Market News Video
AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
from Business Wire News Releases
Analysts See 13% Upside For The Holdings of IEHS
category ETFs
from ETF Channel
CORRECTING and REPLACING OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy
from Business Wire News Releases
AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.